cometriq-cabozantinib-250x250

Cometriq -Cabozantinib

Cometriq (cabozantinib) capsules are kinase inhibitors used to treat people with medullary thyroid cancer (MTC) that has spread to other parts of the body. Common side effects of Cometriq include weight loss, decreased appetite, diarrhea, constipation, nausea, fatigue, mouth discomfort, changes in your sense of taste, weakness, tiredness, hoarseness in your voice, or changes in your hair color.

Reviews

There are no reviews yet.

Be the first to review “Cometriq -Cabozantinib”